Design and synthesis of new inhibitors for protein Farnesyltransferase and Geranylgeranyltransferase type-I

被引：0
|
作者：
Qiao, Yuqin [1 ]
Gao, Jinbo [1 ]
Li, Ding [1 ]
机构：
[1] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 237卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
202-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A new class of type I protein geranylgeranyltransferase (GGTase I) inhibitor
    Sunami, S
    Ohkubo, M
    Sagara, T
    Ono, J
    Asahi, S
    Koito, S
    Morishima, H
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 629 - 632
  • [22] Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I
    Bergman, JM
    Abrams, MT
    Davide, JP
    Greenberg, IB
    Robinson, RG
    Buser, CA
    Huber, HE
    Koblan, KS
    Kohl, NE
    Lobell, RB
    Graham, SL
    Hartman, GD
    Williams, TM
    Dinsmore, CJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1411 - 1415
  • [23] Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues
    Sebti, SM
    Hamilton, AD
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (12) : 2767 - 2782
  • [24] Yeast protein geranylgeranyltransferase type-I: Steady-state kinetics and substrate binding
    Stirtan, WG
    Poulter, CD
    BIOCHEMISTRY, 1997, 36 (15) : 4552 - 4557
  • [25] Inhibitors of farnesyltransferase and geranylgeranyltransferase-I for antitumor therapy: Substrate-based design, conformational constraint and biological activity
    Dinsmore, CJ
    Bell, IM
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (10) : 1075 - 1093
  • [26] MUTANT FARNESYLTRANSFERASE BETA-SUBUNIT OF SACCHAROMYCES-CEREVISIAE THAT CAN SUBSTITUTE FOR GERANYLGERANYLTRANSFERASE TYPE-I BETA-SUBUNIT
    MITSUZAWA, H
    ESSON, K
    TAMANOI, F
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) : 1704 - 1708
  • [27] FARNESYLTRANSFERASE INHIBITORS BLOCK THE NEUROFIBROMATOSIS TYPE-I (NF1) MALIGNANT PHENOTYPE
    YAN, N
    RICCA, C
    FLETCHER, J
    GLOVER, T
    SEIZINGER, BR
    MANNE, V
    CANCER RESEARCH, 1995, 55 (16) : 3569 - 3575
  • [28] Design and synthesis of highly potent and selective protein geranylgeranyltransferase-1 inhibitors
    Pusateri, EE
    Carrico, D
    Peng, HR
    Sebti, S
    Hamilton, AD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U160 - U160
  • [29] Influence of metal ions on substrate binding and catalytic activity of mammalian protein geranylgeranyltransferase type-I
    Zhang, FL
    Casey, PJ
    BIOCHEMICAL JOURNAL, 1996, 320 : 925 - 932
  • [30] Synthesis and evalulation of potent, highly-selective inhibitors of protein geranylgeranyltransferase-I.
    Peng, HR
    Blaskovich, MA
    Sebti, SM
    Hamilton, AD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U654 - U654
12345